Genmab A/S S/Adr

(GMXAY)

By |

Profile

Genmab A/S is an antibody company focused on cancer. Its first marketed product is Arzerra (ofatumumab); development pipeline incl. daratumumab and two proprietary technology platforms; DuoBody (bispecifics) & HexaBody (effector function enhancement).

Contact Information

Website: www.genmab.com
Main Phone: +45 70202728
Address: Bredgade 34E
City / Town: Copenhagen K
Country: DNK
Postal Code: 1260

Issuer Information

Exchange: OTO
Employees: 189
$ 101.45 $ -1.53 (-1.49%)
Last Price 101.45 Change $ -1.53 Change % -1.49 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 101.20 High 101.45 Low 101.00 Prev Close 102.98
Last Trade Volume 1,393 52 Wk Hi 107.13 52 Wk Low 63.60
Market Cap 12.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 120,297,194.00 EPS (TTM) 0.88 PE Ratio 117.60 Exchange OTCPK